Loading…

Advances in Immunotherapy for Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests th...

Full description

Bibliographic Details
Main Authors:	Huang, Boyuan, Zhang, Hongbo, Gu, Lijuan, Ye, Bainxin, Jian, Zhihong, Stary, Creed, Xiong, Xiaoxing
Format:	Online Article Text
Language:	English
Published:	Hindawi Publishing Corporation 2017
Subjects:	Review Article
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337363/ https://www.ncbi.nlm.nih.gov/pubmed/28299344 http://dx.doi.org/10.1155/2017/3597613

Similar Items

Current Immunotherapies for Glioblastoma Multiforme
by: Huang, Boyuan, et al.
Published: (2021)

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies
by: Ye, Baixin, et al.
Published: (2017)

Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis
by: Zhao, Liang, et al.
Published: (2021)

Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research
by: Ye, Baixin, et al.
Published: (2016)

Advances in immunotherapy for glioblastoma multiforme
by: Mahmoud, Ahmad Bakur, et al.
Published: (2022)

Molecular Pathogenesis of Anti-NMDAR Encephalitis
by: Ding, Hao, et al.
Published: (2015)

Cell-based immunotherapy of glioblastoma multiforme
by: Bryukhovetskiy, Igor
Published: (2022)

Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
by: Chowdhury, Selia, et al.
Published: (2021)

Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
by: Xu, Xun, et al.
Published: (2012)

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
by: Jackson, Christopher, et al.
Published: (2011)

Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke
by: Zhao, Liang, et al.
Published: (2018)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
by: Yang, Liu, et al.
Published: (2015)

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
by: Park, Jang Hyun, et al.
Published: (2022)

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
by: Chin, Christopher, et al.
Published: (2018)

An update of advanced nanoplatforms for Glioblastoma Multiforme Management
by: Amaral, Mariana, et al.
Published: (2021)

Engineering chimeric antigen receptor-T cells for cancer treatment
by: Ye, Baixin, et al.
Published: (2018)

Gene Targets of CAR-T Cell Therapy for Glioblastoma
by: Wang, Chaoqun, et al.
Published: (2023)

Glioblastoma multiforme – an overview
by: Urbańska, Kaja, et al.
Published: (2014)

Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
by: Schuessler, Andrea, et al.
Published: (2014)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
by: Pearson, Joshua R. D., et al.
Published: (2020)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
by: Daei Sorkhabi, Amin, et al.
Published: (2022)

Neurocytological Advances in the Treatment of Glioblastoma Multiforme
by: Fiani, Brian, et al.
Published: (2021)

Nanotechnology for Treatment of Glioblastoma Multiforme
by: Michael, Justin S., et al.
Published: (2018)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
by: Yang, Ji’an, et al.
Published: (2020)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
by: Murad, Shafiq, et al.
Published: (2022)

The complement system in glioblastoma multiforme
by: Bouwens van der Vlis, T. A. M., et al.
Published: (2018)

Prion Protein in Glioblastoma Multiforme
by: Ryskalin, Larisa, et al.
Published: (2019)

Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
by: Liu, Zhiye, et al.
Published: (2023)

Glioblastoma Multiforme Stem Cells
by: Dimov, Irena, et al.
Published: (2011)

Glioblastoma Multiforme
by: Sheehan, Jonas M., et al.
Published: (2012)

Advanced Magnetic Resonance Imaging of Glioblastoma Multiforme
by: Ravikanth, Reddy
Published: (2017)

Emergent Pulmonary Embolectomy and Advanced Glioblastoma Multiforme
by: Firstenberg, Michael S., et al.
Published: (2010)

Advanced Bioinformatics Analysis and Genetic Technologies for Targeting Autophagy in Glioblastoma Multiforme
by: Manea, Amanda J., et al.
Published: (2023)

MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
by: Kuan, Chien-Tsun, et al.
Published: (2010)

Drug repurposing for the treatment of glioblastoma multiforme
by: Abbruzzese, Claudia, et al.
Published: (2017)

Targeting Metabolic Remodeling in Glioblastoma Multiforme
by: Wolf, Amparo, et al.
Published: (2010)

Glioblastoma Multiforme Oncogenomics and Signaling Pathways
by: Kanu, Okezie O., et al.
Published: (2009)

Glioblastoma Multiforme Therapy and Mechanisms of Resistance
by: Ramirez, Yulian P., et al.
Published: (2013)

Emerging treatment strategies for glioblastoma multiforme
by: Carlsson, Steven K, et al.
Published: (2014)

Biomarkers for glioblastoma multiforme: status quo
by: Montano, Nicola, et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hajnq1vdirocma9mhr27fv4scn